International COVID-19 Vaccines Safety Tracking Study
(CoVaST-RU): Participation of the Russian Federation

J 2021

International COVID-19 Vaccines Safety Tracking Study (CoVaST-RU): Participation of the Russian Federation

APARTSIN, K.A.; N. A. SVERDLOVA; V. V. KIREEVA; Abanoub RIAD; Miloslav KLUGAR et al.

Základní údaje

Originální název

International COVID-19 Vaccines Safety Tracking Study (CoVaST-RU): Participation of the Russian Federation

Autoři

APARTSIN, K.A.; N. A. SVERDLOVA; V. V. KIREEVA; Abanoub RIAD a Miloslav KLUGAR

Vydání

Profilakticheskaya meditsina, 2021, 2305-4948

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Rusko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/21:00124034

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.17116/profmed20212412131

EID Scopus

2-s2.0-85128414532

Klíčová slova anglicky

COVID-19; vaccination; side effects; Gam-COVID-Vac (Sputnik V); CoviVac; Sputnik Light

Štítky

rivok

Příznaky

Mezinárodní význam

Změněno: 17. 5. 2022 13:04, Mgr. Tereza Miškechová

Anotace

V originále

Side effects associated with COVID-19 vaccines play a crucial role in the public decision regarding the importance and necessity of vaccination. Objective. Global active surveillance of the safety and efficacy of COVID-19 vaccines. The importance of participation of the Russian Federation is determined by obtaining data on the efficacy and safety of vaccines approved for use in the country, such as GamCOVID-Vac (Sputnik V), EpiVacCorona, CoviVac, and Sputnik Light, and comparing them with vaccines used abroad. Material and methods. The international study includes 3 phases to evaluate vaccine efficacy and safety in target populations. The first phase will study adverse reactions associated with primary vaccination, the second phase will investigate the side effects of booster doses, and the third phase will assess the long-term safety and efficacy of COVID-19 vaccines. Validated electronic questionnaires completed by the target population will be used for data collection. Expected results. The study will provide evidence-based data on the efficacy and safety of domestic vaccines in comparison with foreign vaccines. The study protocol is registered at ClinicalTrials.gov under the identifier NCT04834869. Russian Federation (CoVaST-RU) is included in the study on 26 July 2021.

Citovat

APARTSIN, K.A.; N. A. SVERDLOVA; V. V. KIREEVA; Abanoub RIAD a Miloslav KLUGAR. International COVID-19 Vaccines Safety Tracking Study (CoVaST-RU): Participation of the Russian Federation. Profilakticheskaya meditsina. 2021, roč. 24, č. 12, s. 31-40. ISSN 2305-4948. Dostupné z: https://doi.org/10.17116/profmed20212412131.

@article{1830882,
   author = {Apartsin, K.A. and Sverdlova, N. A. and Kireeva, V. V. and Riad, Abanoub and Klugar, Miloslav},
   article_number = {12},
   doi = {https://doi.org/10.17116/profmed20212412131},
   keywords = {COVID-19; vaccination; side effects; Gam-COVID-Vac (Sputnik V); CoviVac; Sputnik Light},
   language = {eng},
   issn = {2305-4948},
   journal = {Profilakticheskaya meditsina},
   title = {International COVID-19 Vaccines Safety Tracking Study (CoVaST-RU): Participation of the Russian Federation},
   url = {https://www.mediasphera.ru/issues/profilakticheskaya-meditsina/2021/12/1230549482021121031?clear_cache=Y},
   volume = {24},
   year = {2021}
}

TY  - JOUR
ID  - 1830882
AU  - Apartsin, K.A. - Sverdlova, N. A. - Kireeva, V. V. - Riad, Abanoub - Klugar, Miloslav
PY  - 2021
TI  - International COVID-19 Vaccines Safety Tracking Study (CoVaST-RU): Participation of the Russian Federation
JF  - Profilakticheskaya meditsina
VL  - 24
IS  - 12
SP  - 31-40
EP  - 31-40
SN  - 23054948
KW  - COVID-19
KW  - vaccination
KW  - side effects
KW  - Gam-COVID-Vac (Sputnik V)
KW  - CoviVac
KW  - Sputnik Light
UR  - https://www.mediasphera.ru/issues/profilakticheskaya-meditsina/2021/12/1230549482021121031?clear_cache=Y
N2  - Side effects associated with COVID-19 vaccines play a crucial role in the public decision regarding the importance and necessity of vaccination. Objective. Global active surveillance of the safety and efficacy of COVID-19 vaccines. The importance of participation of the Russian Federation is determined by obtaining data on the efficacy and safety of vaccines approved for use in the country, such as GamCOVID-Vac (Sputnik V), EpiVacCorona, CoviVac, and Sputnik Light, and comparing them with vaccines used abroad. Material and methods. The international study includes 3 phases to evaluate vaccine efficacy and safety in target populations. The first phase will study adverse reactions associated with primary vaccination, the second phase will investigate the side effects of booster doses, and the third phase will assess the long-term safety and efficacy of COVID-19 vaccines. Validated electronic questionnaires completed by the target population will be used for data collection. Expected results. The study will provide evidence-based data on the efficacy and safety of domestic vaccines in comparison with foreign vaccines. The study protocol is registered at ClinicalTrials.gov under the identifier NCT04834869. Russian Federation (CoVaST-RU) is included in the study on 26 July 2021.
ER  -

APARTSIN, K.A.; N. A. SVERDLOVA; V. V. KIREEVA; Abanoub RIAD a Miloslav KLUGAR. International COVID-19 Vaccines Safety Tracking Study (CoVaST-RU): Participation of the Russian Federation. \textit{Profilakticheskaya meditsina}. 2021, roč.~24, č.~12, s.~31-40. ISSN~2305-4948. Dostupné z: https://doi.org/10.17116/profmed20212412131.

Přehled o publikaci